Article Information
- Received December 2, 2017
- Revision received July 13, 2018
- Accepted July 18, 2018
- First published July 26, 2018.
- Version of record published September 26, 2018.
Author Information
Author contributions
Author contributions: Y.-Q.J. and J.H.M. wrote the first draft of the paper; Y.-Q.J. and J.H.M. edited the paper; Y.-Q.J., A.A., and J.H.M. designed research; Y.-Q.J. and A.A. performed research; Y.-Q.J. and A.S. analyzed data; Y.-Q.J. and J.H.M. wrote the paper.
↵*A.S. and A.A. contributed equally to this work.
Disclosures
- Received December 2, 2017.
- Revision received July 13, 2018.
- Accepted July 18, 2018.
This work was supported by The National Institutes of Health (Grant 2R01NS064004 to J.H.M.), the Craig H. Neilsen Foundation (Grant 261214 to J.H.M.), and the New York State Department of Health Spinal Cord Injury Research Board (Grant C030606GG to J.H.M. and Grant C30860GG to A.A.). We thank Xiuli Wu for histology and immunohistochemistry and the staff of the City University of New York Graduate Center Quantitative Research Consulting Center for statistics consultation. We thank the Andreas Kottman lab at the CUNY School of Medicine for kindly providing the DNase I recombinant used in TUNEL positive control staining.
The authors declare no competing financial interests.
- Correspondence should be addressed to Dr. John H. Martin, Department of Molecular, Cellular, and Biomedical Sciences, City University of New York School of Medicine, 160 Convent Avenue, New York, NY 10031. jmartin{at}ccny.cuny.edu
Other Version
- previous version (July 26, 2018).
- You are viewing the most recent version of this article.
Online Impact